YOSHIO YAMAOKA to Drug Resistance, Microbial
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Drug Resistance, Microbial.
Connection Strength
0.990
-
Prevalence and Antibiotic Resistance Patterns of Helicobacter pylori Infection in Koh Kong, Cambodia. Asian Pac J Cancer Prev. 2020 May 01; 21(5):1409-1413.
Score: 0.627
-
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2021 09; 18(9):613-629.
Score: 0.169
-
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. PLoS One. 2016; 11(12):e0166199.
Score: 0.124
-
Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2024 01; 9(1):56-67.
Score: 0.050
-
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother. 2000 Aug; 44(8):2133-42.
Score: 0.010
-
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother. 2000 Aug; 44(8):2214-6.
Score: 0.010